Evidence map›Paper›PMID 42387578›Full record

ArticleParasites & vectors2026

Field evaluation of a novaluron-based larvicide tablet (MOSQINOk

Ebrima A Jawara, Momodou T Nyassi, Sainey Sanneh, Wandifa Samateh, Balla Gibba, Samuel S Gomez, Harouna M Soumare, Abu Imroz Ali, Shakir Al-Zaidi

Abstract read
In one paragraph

Article in Parasites & vectors, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ebrima A JawaraRUSSELL IPM Ltd, Flintshire,, Deeside, CH5 2NU, UK. ebrima@russellipm.com.
Momodou T NyassiDirectorate of Health Services, Ministry of Health, Banjul, The Gambia.
Sainey SannehDirectorate of Health Research, Ministry of Health, Banjul, The Gambia.
Wandifa SamatehNational Malaria Control Programme (NMCP), Ministry of Health, Kanifing, The Gambia.
Balla GibbaNational Malaria Control Programme (NMCP), Ministry of Health, Kanifing, The Gambia.
Samuel S GomezNational Malaria Control Programme (NMCP), Ministry of Health, Kanifing, The Gambia.
Harouna M SoumareMedical Research Council Unit The Gambia at LSHTM, Serekunda, The Gambia.
Abu Imroz AliRUSSELL IPM Ltd, Flintshire,, Deeside, CH5 2NU, UK.
Shakir Al-ZaidiRUSSELL IPM Ltd, Flintshire,, Deeside, CH5 2NU, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLarval source management remains a potentially important supplementary strategy for malaria vector control, particularly in irrigated agroecosystems, where mosquito breeding habitats are relatively stable and predictable. This study evaluated the operational effectiveness of a novaluron-based larvicide tablet (MOSQINOk

methodsA quasi-experimental controlled field study was conducted between September and December 2025 in two irrigated rice-growing communities in the Central River Region of The Gambia. Janjangbureh was assigned as the intervention site and Sankuli Kunda as the untreated control. Larval habitats were monitored weekly, while adult mosquitoes were collected biweekly using CDC light traps. Difference-in-differences analyses using negative binomial generalized estimating equation models were used to estimate intervention effects.

resultsMOSQINOk

conclusionsThese findings provide preliminary evidence that MOSQINOk

Indexed as

AnophelesInsecticidesMosquito ControlOryzaPhenylurea CompoundsAgricultural IrrigationAgroecologyAnimalsEcosystemGambiaLarvaMalariaMosquito VectorsTabletsInsecticidesnovaluronPhenylurea CompoundsTabletsAnophelesInsect growth regulatorIrrigated riceLarval source managementMalariaNovaluronThe Gambia

Identifiers

PMID42387578
PMCPMC13625327

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.